Symposia: Acute Myeloid Leukemias: Biomarkers and Molecular Markers in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Combination therapy, Translational Research, Clinical Research, Genomics, Health outcomes research, Supportive Care, Diseases, Therapy sequence, Real-world evidence, Treatment Considerations, Registries, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Measurable Residual Disease , Molecular testing
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acute Myeloid Malignancies, AML, Adult, Combination therapy, Translational Research, Clinical Research, Genomics, Health outcomes research, Supportive Care, Diseases, Therapy sequence, Real-world evidence, Treatment Considerations, Registries, Myeloid Malignancies, Biological Processes, Technology and Procedures, Molecular biology, Study Population, Human, Measurable Residual Disease , Molecular testing
Monday, December 9, 2024: 2:45 PM-4:15 PM
Grand Hall B
(Manchester Grand Hyatt San Diego)
Moderators:
Monica Cusan, MD, University Hospital, LMU Munich
and
Francesco Buccisano, MD, University of Rome Tor Vergata
Disclosures:
Buccisano: Servier: Honoraria, Speakers Bureau; Delbert Pharma: Honoraria; Jazz Pharmaceuticals: Honoraria, Speakers Bureau; Novartis: Honoraria.
2:45 PM
3:00 PM
3:30 PM
3:45 PM
4:00 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH